Search Within

Gastrointestinal Oncology Service

  1. "2022"
Formats
  1. Meeting Abstract (167)
  2. Journal Article (138)
  3. Review (14)
  4. Editorial (12)
  5. Correspondence (6)
  6. Guidelines (3)
  7. Miscellaneous (3)
  8. Book Section (1)
  9. Conference Paper (1)
  10. Research Letter (1)
Groups
  1. Department of Medicine (346)
  2. Solid Tumor Oncology Division (346)
  3. Center for Pancreatic Cancer Research (168)
  4. Surgery (89)
  5. Survivorship Research (88)
  6. Epidemiology and Biostatistics (81)

More Groups

People
  1. Eileen O'Reilly (57)
  2. Ghassan Abou-Alfa (53)
  3. Rona Yaeger (39)
  4. Andrea Cercek Hanjis (37)
  5. Yelena Janjigian (37)
  6. William Jarnagin (31)

More People

Years
  1. 2022 (346)
Publications
  1. Journal of Clinical Oncology (76)
  2. Annals of Oncology (40)
  3. Cancer Research (20)
  4. Annals of Surgical Oncology (11)
  5. Pancreas (10)
  6. Journal for ImmunoTherapy of Cancer (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (87)
  2. Oxford University Press (49)
  3. American Association for Cancer Research (31)
  4. Elsevier Inc. (22)
  5. Springer (20)
  6. Nature Publishing Group (19)

More Publishers

Results (346)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Analysis of circulating tumor DNA to predict risk of recurrence in patients with esophageal and gastric cancers
    Journal Article

    Huffman, B. M.; Aushev, V. N.; Budde, G. L.; Chao, J.; Dayyani, F.; Hanna, D.; Botta, G. P.; Catenacci, D. V. T.; Maron, S. B.; Krinshpun, S.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Homologous recombination deficiency in pancreatic cancer: Poly (ADP-ribose) polymerase inhibition, checkpoint inhibition, or a combination of both?
    Correspondence

    Keane, F.; Park, W.; O'Reilly, E. M.
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Infusional therapy: American experience
    Book Section

    Sacks, G. D.; D’angelica, M.; Kemeny, N. E.
    In Vauthey, J. N.; Kawaguchi, Y.; Adam, R. (Eds.) Colorectal Liver Metastasis (2022)

    Fulltext@MSK | Save
  • Provider insights on managing patients on immunotherapy, barriers to clinical trials, and biomarker testing preferences
    Meeting Abstract

    Ackbarali, T.; Neal, J.; Janjigian, Y.; Overman, M.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Botensilimab, a novel innate/adaptive immune activator, plus or minus balstilimab (anti-PD-1) in "cold" and I-O refractory metastatic solid tumors
    Meeting Abstract

    Wilky, B.; El-Khoueiry, A.; Bullock, A.; Tsimberidou, A.; Mahadevan, D.; Margolin, K.; Trent, J.; Bockorny, B.; Moser, J.; Hosein, P.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • A phase 1/2 study of REGN7075 (EGFRxCD28 costimulatory bispecific antibody) in combination with cemiplimab (anti-PD-1) in patients with advanced solid tumors: Initial dose-escalation results
    Meeting Abstract

    Johnson, M.; Lakhani, N.; Girda, E.; Olszanski, A.; Fong, L.; Han, H.; Casey, K.; Li, S.; Visich, J.; Skokos, D.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Exploratory platform trial to evaluate immunotherapy combinations with chemotherapy for the treatment of patients with previously untreated metastatic pancreatic adenocarcinoma (REVOLUTION)
    Meeting Abstract

    Lyman, J.; O'Reilly, E.; Wainberg, Z.; Fisher, G.; Wolff, R.; Ko, A.; O'Hara, M.; Singh, H.; Amaravadi, R.; Kimmelman, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Results from a phase 1 study of CDX-1140, a fully human anti-CD40 agonist monoclonal antibody (mAb), in combination with pembrolizumab
    Meeting Abstract

    Sanborn, R.; Gabrail, N.; Carneiro, B.; O'Hara, M.; Bordoni, R.; Gordon, M.; Khalil, D.; Hauke, R.; Taglienti, C.; Rogalski, M.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Immunogenicity of durvalumab: Analysis of pooled pan-tumor data
    Meeting Abstract

    El-Khoueiry, A.; Zhou, D.; Ozguroglu, M.; Johnson, M.; Abou-Alfa, G.; Makowsky, M.; Krug, L.; Gupta, A.; Chen, C.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Characteristics of the tumor microenvironment in IDH1-mutated cholangiocarcinoma patients from ClarIDHy trial
    Meeting Abstract

    Saatcioglu, H. D.; Valle, J.; Macarulla, T.; Javle, M.; Oh, D. Y.; Goyal, L.; Conway, J.; Iyer, J.; Najdawi, F.; Shah, C.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save